​​Andrew Schwartzberg

Andrew Schwartzberg is one of the nation’s leading affordable housing community developers, having created and operated more than 25,000 affordable housing units over the past two decades. He has also contributed to the investment, development, and operational management of high-end retail centers across the country.

Andrew began his career in the world of investment banking and investment management, holding notable positions at Schroder Wertheim, Inc., SAC Capital Management, Inc., and Convergent Wealth Advisors, where he played instrumental roles in shaping strategies and fostering financial growth.

In addition to investments in the life sciences, Andrew and his wife Jaime’s portfolio spans multi-asset-class real estate and ownership stakes in both domestic and international sports franchises, including the Charlotte Hornets and Leeds United.

Andrew and Jaime are prolific philanthropists who believe their financial success is best shared with those who are working to make the world a better place — locally, nationally, and globally.

Andrew is a graduate of the University of Pennsylvania.

TEAM

Pasha Sarraf, MD, PhD

Dr. Pasha Sarraf is a devoted physician-scientist with deep leadership experience across the business of life sciences, from pharma, to biotech, to Wall Street. His incisive decision-making ensures future value creation on every project he works on.

Read Bio

Andrew N Schwartzberg

Andrew Schwartzberg is one of the leading affordable housing developers in the United States and an active investor in companies focused on advancements in the life sciences.

Read Bio

Aaron Day-Williams, PhD

Dr. Aaron Day-Williams is a highly respected and collaborative computational geneticist and biologist who excels at transforming quantitative assessments of therapeutic hypotheses into actionable target identification, validation, and clinical development.

Read Bio

Dylan Dupuis, PhD

Dr. Dylan Dupuis is an experienced biotech analyst who skillfully applies qualitative and quantitative thinking to identify exceptional value in life sciences opportunities.

Read Bio

James Patterson, MD, PhD

Dr. James Patterson is an inventive physician-scientist and networked entrepreneur, skillfully founding, fundraising, and leading R&D efforts to create impactful therapeutics.

Read Bio

Nathan Edwards

Nathan Edwards has deep expertise in tactical and strategic financial management spanning project incubation to commercial launches, with a proactive and disciplined approach to portfolio optimization.

Read Bio

Nathan Post

Nathan Post is an operator experienced in building, scaling, and transforming biotechnology companies across a range of private investment stages.

Read Bio

Tongtong Zhao, PhD

Dr. Tongtong Zhao is a distinguished scientist and biotech innovator whose expertise spans analytical rigor, foundational research, and technology development central to company building.

Read Bio